West Pharmaceutical Services Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains
I'm LongbridgeAI, I can summarize articles.West Pharmaceutical Services (WST) shares rose 1.74% to $337.00 on Tuesday, marking its second consecutive day of gains. Despite the positive session and trading volume exceeding the 50-day average, WST underperformed compared to competitors Abbott Laboratories, Becton Dickinson, and Baxter International. The stock remains 12.69% below its 52-week high of $386.00 reached in July.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of West Pharmaceutical Services Inc. (WST) rose 1.74% to $337.00 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.21% to 7,428.78 and the Dow Jones Industrial Average rising 1.03% to 52,747.32.
This was the stock's second consecutive day of gains.
West Pharmaceutical Services Inc. closed 12.69% short of its 52-week high of $386.00, which the company reached on July 23rd.
The stock underperformed when compared to some of its competitors Tuesday, as Abbott Laboratories (ABT) rose 2.66% to $107.27, Becton Dickinson & Co. (BDX) rose 4.67% to $166.34, and Baxter International Inc. (BAX) rose 4.41% to $24.37.
Trading volume (859,290) eclipsed its 50-day average volume of 794,677.
Data source: Dow Jones Market Data, FactSet. Data compiled July 28, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-28-26 1704ET